Xeris Biopharma Holdings annual gross margin
2020
2021
2022
2023
2024
2025
Xeris Biopharma Holdings Gross Margin Growth & History (XERS)
Xeris Biopharma Holdings's gross margin was 85.41% for fiscal 2025.
View full Xeris Biopharma Holdings company overviewXeris Biopharma Holdings annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 85.41% | +3.55 pp |
| 2024 | 2024-12-31 | 81.86% | −0.66 pp |
| 2023 | 2023-12-31 | 82.52% | +3.05 pp |
| 2022 | 2022-12-31 | 79.47% | +6.33 pp |
| 2021 | 2021-12-31 | 73.14% | +19.43 pp |
| 2020 | 2020-12-31 | 53.72% | — |
Xeris Biopharma Holdings quarterly gross margin
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 86.41% | +3.05 pp |
| Q1 2026 | 2026-03-31 | 87.28% | +1.80 pp |
| Q4 2025 | 2025-12-31 | 87.24% | +3.01 pp |
| Q3 2025 | 2025-09-30 | 85.22% | +10.26 pp |
| Q2 2025 | 2025-06-30 | 83.37% | −0.42 pp |
| Q1 2025 | 2025-03-31 | 85.48% | +0.18 pp |
| Q4 2024 | 2024-12-31 | 84.23% | — |
| Q3 2024 | 2024-09-30 | 74.95% | −8.08 pp |
| Q2 2024 | 2024-06-30 | 83.79% | +3.67 pp |
| Q1 2024 | 2024-03-31 | 85.31% | — |
| Q3 2023 | 2023-09-30 | 83.03% | +0.72 pp |
| Q2 2023 | 2023-06-30 | 80.12% | −0.87 pp |
| Q4 2022 | 2022-12-31 | 81.11% | +3.77 pp |
| Q3 2022 | 2022-09-30 | 82.30% | +11.42 pp |
| Q2 2022 | 2022-06-30 | 80.99% | +18.98 pp |
| Q1 2022 | 2022-03-31 | 71.37% | −5.95 pp |
| Q4 2021 | 2021-12-31 | 77.34% | — |
| Q3 2021 | 2021-09-30 | 70.89% | +0.53 pp |
| Q2 2021 | 2021-06-30 | 62.01% | — |
| Q1 2021 | 2021-03-31 | 77.32% | — |
| Q3 2020 | 2020-09-30 | 70.35% | — |
Xeris Biopharma Holdings gross margin trends
Over the last five fiscal years, Xeris Biopharma Holdings's gross margin increased from 53.72% to 85.41%, a change of +31.70 percentage points. The latest reported quarter, Q2 2026, shows 86.41%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Xeris Biopharma Holdings source filings ↗